Acute STEMI in a young adult without conventional risk factors: a case report of JAK2-positive essential thrombocythemia. [PDF]
Chen DM +4 more
europepmc +1 more source
Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients. [PDF]
Aydin GS +6 more
europepmc +1 more source
Progression of carotid plaque burden in patients with polycythemia vera and essential thrombocythemia. [PDF]
Kwon SS +6 more
europepmc +1 more source
Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera. [PDF]
Kaddoura R +4 more
europepmc +1 more source
Novel germline <i>JAK2 L808W</i> and <i>E305Vfs*4</i> mutations in familial essential thrombocythemia: Evidence from two pedigrees. [PDF]
Liu J +6 more
europepmc +1 more source
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images. [PDF]
Srisuwananukorn A +11 more
europepmc +1 more source
4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]
Zhang X, Guo X.
europepmc +1 more source
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET). [PDF]
Reeves BN +30 more
europepmc +1 more source
Educational Case: Essential thrombocythemia. [PDF]
Danielson DT, Muir JM.
europepmc +1 more source
Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications. [PDF]
Krecak I +11 more
europepmc +1 more source

